Results
|
486041.
|
|
|
486042.
|
|
|
486043.
|
|
|
486044.
|
|
|
486045.
|
|
|
486046.
|
|
|
486047.
|
|
|
486048.
|
|
|
486049.
|
|
|
486050.
|
|
|
486051.
|
|
|
486052.
|
Formestane, a steroidal aromatase inhibitor after failure of non-steroidal aromatase inhibitors (anastrozole and letrozole): is a clinical benefit still achievable? [electronic resource] by
- Carlini, P
- Frassoldati, A
- De Marco, S
- Casali, A
- Ruggeri, E M
- Nardi, M
- Papaldo, P
- Fabi, A
- Paoloni, F
- Cognetti, F
Producer: 20020716
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 12
Availability: No items available.
|
|
486053.
|
Weekly paclitaxel as first-line chemotherapy and trastuzumab in patients with advanced breast cancer. A Hellenic Cooperative Oncology Group phase II study. [electronic resource] by
- Fountzilas, G
- Tsavdaridis, D
- Kalogera-Fountzila, A
- Christodoulou, C H
- Timotheadou, E
- Kalofonos, C H
- Kosmidis, P
- Adamou, A
- Papakostas, P
- Gogas, H
- Stathopoulos, G
- Razis, E
- Bafaloukos, D
- Skarlos, D
Producer: 20020716
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 12
Availability: No items available.
|
|
486054.
|
|
|
486055.
|
|
|
486056.
|
|
|
486057.
|
|
|
486058.
|
|
|
486059.
|
|
|
486060.
|
|